4197 |
How IVUS Improve LM and Bifurcation Outcomes? |
Akiko Maehara |
Apr. 25. 17 |
4196 |
Why Should Be FFR Believer in Non-LM and LM Bifurcation PCI |
Bon-Kwon Koo |
Apr. 25. 17 |
4195 |
Transcatheter Mitral Valve Replacement - Are We There Yet? |
E Murat Tuzcu |
Apr. 25. 17 |
4194 |
Symptomatic High-Risk AR; Is TAVR a Viable Alternative? |
Jian (James) Ye |
Apr. 25. 17 |
4193 |
Severe Asymptomatic Aortic Stenosis |
Horst Sievert |
Apr. 25. 17 |
4192 |
Current Status of TAVI in Japan |
Kentaro Hayashida |
Apr. 25. 17 |
4191 |
Valve-in-Valve |
Darren L. Walters |
Apr. 25. 17 |
4190 |
Technical Lessons for TAVR; Expert Experience |
Alan C. Yeung |
Apr. 25. 17 |
4189 |
DECISION-CTO Trial: Treat or Not Treat CTO |
Seung-Whan Lee |
Apr. 25. 17 |
4188 |
Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC |
Jung-Min Ahn |
Apr. 25. 17 |